Impact of Isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: An epidemiological model

Journal of Acquired Immune Deficiency Syndromes

Volumn 66, Issue 5, 2014, Pages 552-558

  Dowdy, David W ^a,b   Golub, Jonathan E ^a,b   Saraceni, Valeria ^c   Moulton, Lawrence H ^b   Cavalcante, Solange C ^c,e   Cohn, Silvia ^a   Pacheco, Antonio G ^d   Chaisson, Richard E ^a,b   Durovni, Betina ^b,f  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Municipal Health Secretariat   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e Funda??o Oswaldo Cruz   (Brazil)

^f FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Brazil; HIV; Infectious disease transmission; Isoniazid; Theoretical models; Tuberculosis

Indexed keywords

ISONIAZID;

ADOLESCENT; ADULT; ANTIVIRAL THERAPY; ARTICLE; BACTERIAL TRANSMISSION; BRAZIL; DISEASE SURVEILLANCE; FEASIBILITY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MORTALITY; POPULATION; PRIORITY JOURNAL; SCREENING; SENSITIVITY ANALYSIS; TUBERCULOSIS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; BRAZIL; HIV INFECTIONS; HUMANS; ISONIAZID; MIDDLE AGED; TUBERCULOSIS; URBAN POPULATION; YOUNG ADULT;

EID: 84904468333     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000219     Document Type: Article

References (35)

1. World Health Organization, Stop TB Department. Guidelines for Intensified Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living with HIV in Resource-Constrained Settings. Geneva, Switzerland: World Health Organization; 2011.
2. Comstock GW, Ferebee SH, Hammes LM. A controlled trial of communitywide isoniazid prophylaxis in Alaska. Am Rev Respir Dis. 1967;95: 935-943.
3. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28-106.
4. Pape JW, Jean SS, Ho JL, et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993;342:268-272.
5. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1: CD000171.
6. Bucher HC, Griffith LE, Guyatt GH, et al. Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials. AIDS. 1999;13:501-507.
7. Whalen CC, Johnson JL, Okwera A, et al; for the Uganda-Case Western Reserve University Research Collaboration. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med. 1997;337:801-808.
8. Comstock GW, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119:827-830.
9. Horwitz O. Long-term results of the chemoprophylactic trial in Greenland. Bull Int Union Tuberc. 1968;41:167-168.
10. Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-1021.
11. Chaisson RE, Martinson NA. Tuberculosis in Africa-combating an HIV-driven crisis. N Engl J Med. 2008;358:1089-1092.
12. Mills HL, Cohen T, Colijn C. Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure. J R Soc Interf. 2011;8:1510-1520.
13. Churchyard GJ, Fielding KL, Lewis JJ, et al. A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med. 2014;370:301-310.
14. Samandari T, Agizew TB, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377:1588-1598.
15. Durovni B, Saraceni V, Moulton LH, et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in the TB/HIV in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster randomised trial. Lancet Infect Dis. 2013;13:852-858.
16. Moulton LH, Golub JE, Durovni B, et al. Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention. Clin Trials. 2007;4:190-199.
17. Durovni B, Cavalcante SC, Saraceni V, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS. 2010;24(suppl 5):S49-S56.
18. Rhoda DA, Murray DM, Andridge RR, et al. Studies with staggered starts: multiple baseline designs and group-randomized trials. Am J Public Health. 2011;101:2164-2169.
19. Brown CA, Lilford RJ. The stepped wedge trial design: a systematic review. BMC Med Res Methodol. 2006;6:54.
20. Municipal Secretariat of Health and Civil Defense, Rio de Janeiro. Epidemiological Bulletin (Coordination of Infectious Diseases: AIDS, Tuberculosis, Leprosy). Rio de Janeiro, Brazil: Municipal Secretariat of Health and Civil Defense; 2008.
21. Municipal Secretariat of Health and Civil Defense, Rio de Janeiro. Infectious Diseases: Information and Epidemiological Data on AIDS and Tuberculosis. Rio de Janeiro, Brazil: Municipal Secretariat of Health and Civil Defense. Available at: http://www.rio.rj.gov.br/web/smsdc/ exibeconteudo? article-id=126082. Accessed November 29, 2011.
22. World Health Organization. Global Tuberculosis Report 2012. Geneva, Switzerland: WHO Press; 2012.
23. Gilks CF, Godfrey-Faussett P, Batchelor BIF, et al. Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS. 1997;11:911-918.
24. Horsburgh CR Jr, O'Donnell M, Chamblee S, et al. Revisiting rates of reactivation tuberculosis: a population-based approach. Am J Respir Crit Care Med. 2010;182:420-425.
25. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Report on the Global AIDS Epidemic 2012. Geneva, Switzerland: UNAIDS; 2012.
26. Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIVinfected patients in Rio de Janeiro, Brazil. AIDS. 2007;21:1441-1448.
27. Cohen T, Lipsitch M, Walensky RP, et al. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV- tuberculosis coinfected populations. Proc Natl Acad Sci U S A. 2006;103: 7042-7047.
28. Sutherland I, Svandová E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli: 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. Tubercle. 1982;63:255-268.
29. Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect. 1997;119:183-201.
30. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352:570-585.
31. Sánchez MS, Lloyd-Smith JO, Williams BG, et al. Incongruent HIV and tuberculosis co-dynamics in Kenya: interacting epidemics monitor each other. Epidemics. 2009;1:14-20.
32. Municipal Secretariat of Health, Rio de Janeiro. Vital Statistics. Rio de Janeiro, Brazil: Municipal Secretariat of Health. Available at: http://www. rio.rj.gov.br/web/sms/analise-situacoes-saude. Accessed January 2, 2014.
33. Guwatudde D, Debanne SM, Diaz M, et al. A re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa. Prev Med. 2004;39: 1036-1046.
34. Bekker LG, Wood R. The changing natural history of tuberculosis and HIV coinfection in an urban area of hyperendemicity. Clin Infect Dis. 2010;50(suppl 3):S208-S214.
35. Kritzinger FE, den Boon S, Verver S, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health. 2009;14:136-142.